Latest stories on TOVX
Theriva Biologics GAAP EPS of -$0.03
Seeking Alpha42 · neutralearnings
Theriva Biologics, Inc. (TOVX) files 8-K: Items 2.02, 9.01
SEC 8-K50 · neutralgeneral
Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
GlobeNewswire58 · neutralearnings
Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
Business Insider58 · neutralearnings
Theriva Biologics, Inc. (TOVX) files 8-K
SEC 8-K58 · neutralm&a
Theriva Biologics announces results from VIRAGE Phase 2b trial of VCN-01
The Fly59 · neutralproduct/pr
Theriva Biologics, Inc. (TOVX) files 8-K
SEC 8-K50 · neutralgeneral
Theriva Biologics GAAP EPS of -$0.07 misses by $0.01
Seeking Alpha34 · bearishearnings
Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results
Business Insider56 · neutralearnings
Theriva Biologics, Inc. (TOVX) files 8-K
SEC 8-K50 · neutralgeneral
Theriva Biologics Expands Stock Incentive and Governance Plans
TipRanks50 · neutralgeneral
Theriva Biologics, Inc. (TOVX) files 8-K
SEC 8-K50 · neutralgeneral
Theriva Biologics launches VIRAGE2 metastatic pancreatic trial
TipRanks59 · neutralproduct/pr
Theriva Biologics, Inc. (TOVX) files 8-K
SEC 8-K50 · neutralgeneral
Theriva Biologics’ VCN-01 Trial Shows Prolonged Survival for Resistant Head & Neck Cancer Patients
MarketChameleon73 · bullishproduct/pr
Theriva Biologics, Inc. (TOVX) files 8-K
SEC 8-K50 · neutralgeneral
Theriva Biologics Faces Quorum Issue Delaying Warrant Vote
TipRanks34 · bearishgeneral